Monterey Bio Acquisition priced its IPO of 10 million units at $10 each.
Units begin trading on the Nasdaq today under MTRYU.
Once the securities begin separate trading, shares and warrants are expected to list under MTRY and MTRYW.
The SPAC is targeting the biotech industry.
The offering is expected to close Oct. 5.
Chardan is sole book-running manager in the offering. The underwriter has an option to purchase up to an additional 1.5 million units to cover over-allotments, if any. Read more.
